Market Overview

Covidien Announces Continued Relationship with NYSE Euronext

Related COV
Synergy Rallies 18% Following News of Paulson & Co. Stake
John Paulson Continues To Bet On Health Care And TV
Related NYX
What a Phone Call from My Aunt Told Me About the Stock Market
Michael Kors to Replace NYSE Euronext in S&P Index on November 12

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that Mallinckrodt plc intends to apply to list its ordinary shares on the New York Stock Exchange (NYSE) to trade under the symbol MNK.

As previously announced, Covidien plans to spin off its Pharmaceuticals business into Mallinckrodt, a stand-alone company, a process expected to be completed in mid-2013.

Posted-In: News


Related Articles (COV + NYX)

Get Benzinga's Newsletters